Patents by Inventor Alan Corbin

Alan Corbin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating estrogen receptor positive carcinoma with 17 ?-dihydroequilin
    Patent number: 7005429
    Abstract: This invention provides a method of treating estrogen receptor positive carcinoma in a mammal in need thereof which comprises administering an antineoplastic amount of 17(?-dihydroequilin or a mammalian metabolic conjugate thereof orally, parenterally, transdermally, topically, rectally, intravaginally, intranasally, or intrabronchially. As such, the compounds of this invention are useful in treating estrogen receptor positive carcinomas such as carcinomas of the breast, uterus, ovary, fallopian tube, cervix, vagina, liver, pituitary, central nervous system, hypothalamus, bone, skin, kidney, urethra, prostate, and the like.
    Type: Grant
    Filed: September 26, 2001
    Date of Patent: February 28, 2006
    Assignee: Wyeth
    Inventors: Michael S. Dey, Frederick J. Bex, Alan Corbin
  • Method of treating estrogen receptor positive carcinoma 17 alpha-dihydroequilin
    Publication number: 20020035101
    Abstract: This invention provides a method of treating estrogen receptor positive carcinoma in a mammal in need thereof which comprises administering an antineoplastic amount of 17(&agr;-dihydroequilin or a mammalian metabolic conjugate thereof orally, parenterally, transdermally, topically, rectally, intravaginally, intranasally, or intrabronchially. As such, the compounds of this invention are useful in treating estrogen receptor positive carcinomas such as carcinomas of the breast, uterus, ovary, fallopian tube, cervix, vagina, liver, pituitary, central nervous system, hypothalamus, bone, skin, kidney, urethra, prostate, and the like.
    Type: Application
    Filed: September 26, 2001
    Publication date: March 21, 2002
    Applicant: American Home Products Corporation
    Inventors: Michael S. Dey, Frederick J. Bex, Alan Corbin
  • Method of treating estrogen receptor positive carcinoma with 17 &agr;-dihydroequilin
    Patent number: 6342491
    Abstract: This invention provides a method of treating estrogen receptor positive carcinoma in a mammal in need thereof which comprises administering an antineoplastic amount of 17&agr;-dihydroequilin or a mammalian metabolic conjugate thereof orally, parenterally, transdermally, topically, rectally, intravaginally, intranasally, or intrabronchially. As such, the compounds of this invention are useful in treating estrogen receptor positive carcinomas such as carcinomas of the breast, uterus, ovary, fallopian tube, cervix, vagina, liver, pituitary, central nervous system, hypothalamus, bone, skin, kidney, urethra, prostate, and the like.
    Type: Grant
    Filed: November 10, 1992
    Date of Patent: January 29, 2002
    Assignee: American Home Products Corporation
    Inventors: Michael S. Dey, Frederick J. Bex, Alan Corbin
  • Use of LRH and LRH agonists
    Patent number: 4338305
    Abstract: The use of LRH and LRH agonists as contraceptives in the planetal mammal is disclosed.
    Type: Grant
    Filed: August 11, 1975
    Date of Patent: July 6, 1982
    Assignee: American Home Products Corporation
    Inventor: Alan Corbin
  • Claudogenic-interceptive nonapeptide
    Patent number: 4272432
    Abstract: The invention embraces the novel nonapeptide L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-alanyl-L-leucyl -L-arginyl-L-prolinethylamide, intermediates for its production and its use as a claudogenic-interceptive agent.
    Type: Grant
    Filed: November 13, 1974
    Date of Patent: June 9, 1981
    Assignee: American Home Products Corporation
    Inventors: John P. Yardley, Alan Corbin